FDA Says No to Sodium Oxybate Treatment for Fibromyalgia
Recently I told you that an FDA panel had recommended not approving sodium oxybate for fibromyalgia. On Monday, the FDA agreed with the panel's decision. They sent Jazz Pharmaceuticals, Inc., the manufacturer of sodium oxybate, a complete response letter (CRL) regarding the company's New Drug Application (NDA) for JZP-6 (sodium... Read more




